Latest / Health News Today | 2 Min News | The Daily News Now!
Fixed-Duration Therapy Changes CLL Treatment | Health and Fitness News
CLL treatment is undergoing a major shift with fixed-duration therapy—patients now take meds for a set time (usually 1-2 years) instead of lifelong treatment, offering a clear endpoint, fewer side effects, and potentially delaying drug resistance. While promising, it’s not for all—doctors evaluate genetic markers to determine eligibility, and drugs like venetoclax require close monitoring. Common regimens combine venetoclax with monoclonal antibodies or BTK inhibitors, lasting 12-14 months, with ongoing research expanding options. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.